Embody vs Ro: GLP-1 Cost & Plans Compared
Embody vs Ro compared on price, medication format and commitment terms. See which GLP-1 programme fits, and what each actually costs over a year.
Quick Verdict
Editorial Take
Best Overall: Neither can be called the overall winner from published information. Embody publishes semaglutide at $69/month. Ro does not publish a headline monthly rate, so its cost cannot be compared until you complete intake — which is itself worth knowing before you start.
Best for Budget: Not determinable in advance. Embody publishes semaglutide at $69/month. Ro does not publish a headline monthly rate, so its cost cannot be compared until you complete intake — which is itself worth knowing before you start.
Best for Fast Approval: Both run fully online intake with licensed clinician review, so approval speed is unlikely to separate them. Embody quotes shipping as free, 1–2 days; Ro quotes included with membership.
At a Glance Comparison
| Feature | Embody | Ro |
|---|---|---|
| Semaglutide price | $69/month | Not published before intake |
| Tirzepatide price | $119/month | Not published before intake |
| Needle-free oral option | No | Yes |
| Brand-name medication | No | Yes |
| Insurance support | No | Yes |
| Shipping | Free, 1–2 days | Included with membership |
Who Should Choose Embody
Choose Embody if:
- ✓You want the lowest flat monthly rate on both molecules, with no prepayment required
- ✓You are comparing on a published semaglutide rate of $69/month
- ✓You accept the trade-off that no multi-month discount, so the rate cannot be lowered further
Who Should Choose Ro
Choose Ro if:
- ✓You want FDA-approved branded GLP-1s from $39 to start, with a dedicated insurance concierge
- ✓You are comfortable getting a quote at intake rather than shopping on a published price
- ✓You want a needle-free oral option
- ✓You want FDA-approved brand-name medication, not only compounded
- ✓You accept the trade-off that ongoing cost depends on coverage and is not quotable before intake
Embody Deep Dive
Embody leads with the lowest flat monthly rate on both molecules, with no prepayment required. Semaglutide is published at $69/month, tirzepatide at $119/month. The honest caveat is that no multi-month discount, so the rate cannot be lowered further.
How It Works
- Complete the online intake covering health history and weight goals
- A licensed clinician reviews your information and prescribes if appropriate
- Medication ships — free, 1–2 days
- Continue with clinician support for dose adjustment
Medications Offered
- ✓Semaglutide from $69/month
- ✓Tirzepatide from $119/month
Pricing
$69/month semaglutide. Free, 1–2 days.
- ✓The lowest flat monthly rate on both molecules, with no prepayment required
- ✓Free, 1–2 days
- ✗No multi-month discount, so the rate cannot be lowered further
- ✗Compounded medication is not an FDA-approved finished product
Ro Deep Dive
Ro leads with FDA-approved branded GLP-1s from $39 to start, with a dedicated insurance concierge. It does not publish a headline monthly rate ahead of intake. The honest caveat is that ongoing cost depends on coverage and is not quotable before intake.
How It Works
- Complete the online intake covering health history and weight goals
- A licensed clinician reviews your information and prescribes if appropriate
- Medication ships — included with membership
- Continue with clinician support for dose adjustment
Medications Offered
- ✓Semaglutide, pricing quoted at intake
- ✓Needle-free oral tablet option
- ✓FDA-approved brand-name GLP-1 medication
Pricing
Pricing quoted at intake. Included with membership.
- ✓FDA-approved branded GLP-1s from $39 to start, with a dedicated insurance concierge
- ✓Included with membership
- ✓Needle-free oral option available
- ✓Insurance support available
- ✗Ongoing cost depends on coverage and is not quotable before intake
Honest Tradeoffs
Pricing
Embody publishes semaglutide at $69/month. Ro does not publish a headline monthly rate, so its cost cannot be compared until you complete intake — which is itself worth knowing before you start.
Medication Types
Ro offers FDA-approved brand-name medication as well as compounded; Embody is compounded-only. Compounded products are not FDA approved and have not been through the trials the branded versions have, so this is the most consequential difference between these two.
Doctor Involvement
Both require review by a licensed U.S. clinician before dispensing, and neither is a subscribe-and-ship product. Ongoing support for dose titration is included at both.
Delivery Speed
Embody: Free, 1–2 days. Ro: Included with membership. In practice the gap between clinician review times usually matters more than the shipping estimate.
Subscription Model
Neither advertises a rate that depends on prepaying a term, so the published monthly figures are directly comparable.
Pricing Breakdown
| Aspect | Embody | Ro |
|---|---|---|
| Semaglutide, monthly | $69/month | Not published before intake |
| Tirzepatide, monthly | $119/month | Not published before intake |
| 6-month semaglutide total | $414 | Not computable from published pricing |
| 12-month semaglutide total | $828 | Not computable from published pricing |
| Commitment required for best rate | No | No |
What You Actually Pay Over 12 Months
Advertised starting prices are the least useful number in this comparison, so below is what each provider costs across a realistic course of treatment rather than on day one. Pricing verified July 30, 2026; confirm the final figure at enrollment, as offers change.
| Embody | Ro | |
|---|---|---|
| First month | $69/month | Not published before intake |
| 6-month total | $414 | Not computable from published pricing |
| 12-month total | $828 | Not computable from published pricing |
| Price includes | Medication, clinician review and ongoing dose support. Shipping: free, 1–2 days. | Medication, clinician review and ongoing dose support. Shipping: included with membership. |
| What can raise it | No prepaid term is required to reach the advertised rate. | No prepaid term is required to reach the advertised rate. |
Embody publishes semaglutide at $69/month. Ro does not publish a headline monthly rate, so its cost cannot be compared until you complete intake — which is itself worth knowing before you start. Neither advertises a rate that depends on prepaying a term, so the published monthly figures are directly comparable. Ro offers FDA-approved brand-name medication as well as compounded; Embody is compounded-only. Compounded products are not FDA approved and have not been through the trials the branded versions have, so this is the most consequential difference between these two.
Medication Comparison
Semaglutide
Embody publishes semaglutide at $69/month. Ro does not publish a headline monthly rate, so its cost cannot be compared until you complete intake — which is itself worth knowing before you start.
Tirzepatide
Tirzepatide pricing is not published by both providers, so the dual-agonist comparison cannot be made from public information. Ask at intake if tirzepatide is what you want.
Which Provider Offers What
Ro offers a needle-free oral option; Embody is injection-only. Ro offers FDA-approved brand-name medication as well as compounded; Embody is compounded-only. Compounded products are not FDA approved and have not been through the trials the branded versions have, so this is the most consequential difference between these two.
Results Expectations
Safety Considerations
Side Effects
Both carry the GLP-1 side-effect profile: nausea, vomiting, diarrhoea, constipation and abdominal discomfort, typically dose-related and most pronounced during titration. GLP-1 medications carry serious warnings including the risk of thyroid C-cell tumours and should not be used by anyone with a personal or family history of medullary thyroid carcinoma or MEN 2. Disclose your full history at intake.
Doctor Supervision
Both require review by a licensed U.S. clinician before dispensing and provide ongoing support for dose adjustment.
Prescription Requirement
Ro offers FDA-approved brand-name medication as well as compounded; Embody is compounded-only. Compounded products are not FDA approved and have not been through the trials the branded versions have, so this is the most consequential difference between these two.
How We Evaluated These Providers
We evaluated both providers based on the following criteria:
- ✓Published monthly pricing for each molecule, and the six and twelve-month totals that follow from it
- ✓Whether the advertised rate requires a prepaid term
- ✓Medication formats offered, including any needle-free option
- ✓Regulatory status: compounded against FDA-approved brand-name
- ✓Whether insurance can be used at all
- ✓Shipping as published by each provider
Final Verdict
Editorial Take
Best for Budget Users
Not determinable from published pricing. Embody publishes semaglutide at $69/month. Ro does not publish a headline monthly rate, so its cost cannot be compared until you complete intake — which is itself worth knowing before you start.
Best for Fast Results
Tied, and neither should claim otherwise. Same molecules, comparable clinician-led process; the pace of results depends on titration and adherence rather than the provider.
Best for Doctor Supervision
Comparable. Both require licensed clinician review before dispensing and include ongoing dose support.
Best Premium Experience
Embody for the lowest flat monthly rate on both molecules, with no prepayment required; Ro for FDA-approved branded GLP-1s from $39 to start, with a dedicated insurance concierge. Which reads as premium depends on whether you value the programme around the medication or the lowest number on the invoice.
Frequently Asked Questions
Read Our Full Reviews
Related Comparisons
Advertising & Affiliate Disclosure: We may receive compensation when you click on links to partners featured on this site. Our rankings and recommendations are based on our independent research methodology and editorial standards, not on sponsorship or payment. Some links are affiliate links, which means we may earn a commission at no extra cost to you if you make a purchase.
Medical Disclaimer: The content on this site is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider for medical questions, treatment decisions, or emergency care. Do not disregard professional medical advice or delay seeking it based on information found here.